• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS CRPHS; CARDIAC C-REACTIVE PROTEIN, ANTIGEN, ANTISERUM, AND CONTROL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS CRPHS; CARDIAC C-REACTIVE PROTEIN, ANTIGEN, ANTISERUM, AND CONTROL Back to Search Results
Catalog Number 04628918190
Device Problem Non Reproducible Results (4029)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/21/2023
Event Type  malfunction  
Event Description
The initial reporter complained of discrepant results for 1 patient sample tested for crphs on a cobas 6000 c501 module.The initial result was 589.14 mg/l accompanied by an invalidating data flag.The sample was repeated with a 1:20 dilution and the result was 281.10 mg/l.The sample was then repeated using "ifi" technology and the result was 137.4 mg/l.This result was believed to be correct.On (b)(6) 2023 the sample was repeated and the result was 580.97 mg/l accompanied by an invalidating data flag.The sample was repeated again with a 1:20 dilution and the result was 275.35 mg/l.Additional results were provided from 28-sep-2023: the result was 596.94 mg/l accompanied by an invalidating data flag.The repeat result in decreased mode was 272.58 mg/l.
 
Manufacturer Narrative
The c501 module serial number was (b)(6).
 
Manufacturer Narrative
Calibration and qc were acceptable.No issues were identified during a review of the alarm trace data.The sample concentration for the patient was relatively high.Product labeling states: "determine samples having higher concentrations via the rerun function.Dilution of samples via the rerun function is a 1:15 dilution." the customer used a 1:20 dilution.The sample was repeated using "ifi" technology.Different analytical methods may produce different results.The investigation did not identify a product problem.The event was due to a sample handling issue (non-validated dilution).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CRPHS
Type of Device
CARDIAC C-REACTIVE PROTEIN, ANTIGEN, ANTISERUM, AND CONTROL
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key17965983
MDR Text Key326053931
Report Number1823260-2023-03350
Device Sequence Number1
Product Code NQD
UDI-Device Identifier04015630921508
UDI-Public04015630921508
Combination Product (y/n)Y
Reporter Country CodeMX
PMA/PMN Number
K053603
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number04628918190
Device Lot Number72884801
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/22/2023
Initial Date FDA Received10/19/2023
Supplement Dates Manufacturer Received11/27/2023
Supplement Dates FDA Received12/05/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
CIPROFLOXACIN.
Patient Age38 YR
Patient SexFemale
-
-